Search Results - "GEDULIN, BRONISLAVA"
-
1
Exenatide (Exendin-4) Improves Insulin Sensitivity and β-Cell Mass in Insulin-Resistant Obese fa/fa Zucker Rats Independent of Glycemia and Body Weight
Published in Endocrinology (Philadelphia) (01-04-2005)“…The effects of the incretin mimetic exenatide (exendin-4) on metabolic parameters, insulin sensitivity, and β-cell mass were examined in nondiabetic,…”
Get full text
Journal Article -
2
Ileo-colonic delivery of conjugated bile acids improves glucose homeostasis via colonic GLP-1-producing enteroendocrine cells in human obesity and diabetes
Published in EBioMedicine (01-05-2020)“…The bile acid (BA) pathway plays a role in regulation of food intake and glucose metabolism, based mainly on findings in animal models. Our aim was to…”
Get full text
Journal Article -
3
Inhibition of apical sodium-dependent bile acid transporter as a novel treatment for diabetes
Published in American journal of physiology: endocrinology and metabolism (01-01-2012)“…Bile acids are recognized as metabolic modulators. The present study was aimed at evaluating the effects of a potent Asbt inhibitor (264W94), which blocks…”
Get more information
Journal Article -
4
Safety, tolerability and pharmacodynamics of apical sodium-dependent bile acid transporter inhibition with volixibat in healthy adults and patients with type 2 diabetes mellitus: a randomised placebo-controlled trial
Published in BMC gastroenterology (05-01-2018)“…Pathogenesis in non-alcoholic steatohepatitis (NASH) involves abnormal cholesterol metabolism and hepatic accumulation of toxic free cholesterol. Apical…”
Get full text
Journal Article -
5
Exenatide does not evoke pancreatitis and attenuates chemically induced pancreatitis in normal and diabetic rodents
Published in American journal of physiology: endocrinology and metabolism (01-12-2010)“…The risk of developing pancreatitis is elevated in type 2 diabetes and obesity. Cases of pancreatitis have been reported in type 2 diabetes patients treated…”
Get more information
Journal Article -
6
Pharmacokinetics and pharmacodynamics of exenatide following alternate routes of administration
Published in International journal of pharmaceutics (22-05-2008)“…Exenatide is a 39-amino acid peptide incretin mimetic approved for adjunctive treatment of type 2 diabetes. It shares several glucoregulatory activities with…”
Get full text
Journal Article -
7
Improved glucose control and reduced body weight in rodents with dual mechanism of action peptide hybrids
Published in PloS one (22-10-2013)“…Combination therapy is being increasingly used as a treatment paradigm for metabolic diseases such as diabetes and obesity. In the peptide therapeutics realm,…”
Get full text
Journal Article -
8
Role of endogenous amylin in glucagon secretion and gastric emptying in rats demonstrated with the selective antagonist, AC187
Published in Regulatory peptides (10-12-2006)“…Amylin is a 37-amino acid polypeptide co-secreted with insulin from the pancreatic β-cells. It complements insulin's stimulation of the rate of glucose…”
Get full text
Journal Article -
9
Glucose-lowering and insulin-sensitizing actions of exendin-4: studies in obese diabetic (ob/ob, db/db) mice, diabetic fatty Zucker rats, and diabetic rhesus monkeys (Macaca mulatta)
Published in Diabetes (New York, N.Y.) (01-05-1999)“…Glucose-lowering and insulin-sensitizing actions of exendin-4: studies in obese diabetic (ob/ob, db/db) mice, diabetic fatty Zucker rats, and diabetic rhesus…”
Get full text
Journal Article -
10
Biological activity of AC3174, a peptide analog of exendin-4
Published in Regulatory peptides (07-06-2007)“…Exenatide, the active ingredient of BYETTA® (exenatide injection), is an incretin mimetic that has been developed for the treatment of patients with type 2…”
Get full text
Journal Article -
11
-
12
Hypoglycemia overrides amylin-mediated regulation of gastric emptying in rats
Published in Diabetes (New York, N.Y.) (1998)“…Amylin, a 37-amino acid peptide hormone co-secreted with insulin, potently governs the rate of gastric emptying. Hypoglycemia, in the absence of agents such as…”
Get full text
Journal Article -
13
Dose-response for inhibition by amylin of cholecystokinin-stimulated secretion of amylase and lipase in rats
Published in Regulatory peptides (15-08-2005)“…The neuroendocrine hormone amylin, cosecreted with insulin from pancreatic β-cells in response to nutrient ingestion, has several physiologic actions to limit…”
Get full text
Journal Article -
14
Effects of Ileo-Colonic Delivery of Conjugated Bile Acids on Glucose Metabolism, GLP-1, and Body Weight in Patients with Obesity and Type 2 Diabetes Mellitus—A Randomized Controlled Trial
Published in Diabetes (New York, N.Y.) (01-07-2018)“…Bile acid secretion increases significantly after Roux-in-Y gastric bypass and may play a role in weight loss after bariatric surgery. The acute…”
Get full text
Journal Article -
15
446 – Modulation of Bile Acids Pathway in Obesity and Type 2 Diabetes
Published in Gastroenterology (New York, N.Y. 1943) (01-05-2019)Get full text
Journal Article -
16
Amylin secretion from the perfused pancreas: dissociation from insulin and abnormal elevation in insulin-resistant diabetic rats
Published in Biochemical and biophysical research communications (31-10-1991)“…Amylin has been co-secreted from pancreatic islet beta-cells in constant proportion with insulin in some studies. We measured basal and glucose-stimulated…”
Get more information
Journal Article -
17
PYY[3-36] administration decreases the respiratory quotient and reduces adiposity in diet-induced obese mice
Published in The Journal of nutrition (01-01-2006)“…In rodents, weight reduction after peptide YY[3-36] (PYY[3-36]) administration may be due largely to decreased food consumption. Effects on other processes…”
Get more information
Journal Article -
18
-
19
Dose-response for glucagonostatic effect of amylin in rats
Published in Metabolism, clinical and experimental (1997)“…Glucagon secretion from pancreatic α cells is inhibited by insulin from β cells. Amylin is a partner hormone to insulin cosecreted in response to nutrient…”
Get full text
Journal Article -
20
Exenatide (exendin-4) improves insulin sensitivity and {beta}-cell mass in insulin-resistant obese fa/fa Zucker rats independent of glycemia and body weight
Published in Endocrinology (Philadelphia) (01-04-2005)“…The effects of the incretin mimetic exenatide (exendin-4) on metabolic parameters, insulin sensitivity, and beta-cell mass were examined in nondiabetic,…”
Get full text
Journal Article